Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1967984Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pathology
- Microbiology & Immunology
NIH Funding · FY2024
Linked Award Amount
$1.3M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#10,346
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Pengbo Zhou as a PI. Multi-PI records show the full award amount for context.
- 1R01CA287724-01A1R01Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancer$711Kaward amount
- 5R01CA273716-02R01UBR5's mechanisms of action in tumorigenesis and immunoregulation$622.5Kaward amount
Award organization
Organizations that administered FY2024 awards listing Pengbo Zhou as a PI.
FY2024 award administered by Weill Cornell Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardWeill Cornell Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Pengbo Zhou.